今开:0.0 | 昨收:12.005 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:1.654349025E9 |
$Synta Pharmaceuticals(SNTA)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2016-04-28 AccNo: 0001193125-16-560394 Size: 55 KB 网页链接
$Synta Pharmaceuticals(SNTA)$ 8-K - Current report Filed: 2016-04-22 AccNo: 0001104659-16-113559 Size: 63 KBItem 1.02: Termination of a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Synta Pharmaceuticals(SNTA)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-04-15 AccNo: 0000919574-16-012488 Size: 146 KB 网页链接
$Synta Pharmaceuticals(SNTA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-04-15 AccNo: 0001104659-16-111568 Size: 77 KB 网页链接
$Synta Pharmaceuticals(SNTA)$ 8-K - Current report Filed: 2016-04-15 AccNo: 0001104659-16-111567 Size: 77 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Synta Pharmaceuticals(SNTA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-04-14 AccNo: 0001104659-16-111525 Size: 5 MB 网页链接
$Synta Pharmaceuticals(SNTA)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-04-14 AccNo: 0001104659-16-111349 Size: 1 MB 网页链接
$Synta Pharmaceuticals(SNTA)$ 8-K - Current report Filed: 2016-04-14 AccNo: 0001104659-16-111524 Size: 5 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Synta Pharmaceuticals(SNTA)$ 8-K - Current report Filed: 2016-04-14 AccNo: 0001104659-16-111348 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 5.01: Changes in Control of RegistrantItem 5.02: Departure of...
$Synta Pharmaceuticals(SNTA)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-03-15 AccNo: 0001047469-16-011140 Size: 6 MB 网页链接